203 related articles for article (PubMed ID: 33772729)
41. Alternative donor: αß/CD19 T-cell-depleted haploidentical hematopoietic stem cell transplantation for sickle cell disease.
Foell J; Kleinschmidt K; Jakob M; Troeger A; Corbacioglu S
Hematol Oncol Stem Cell Ther; 2020 Jun; 13(2):98-105. PubMed ID: 32202248
[TBL] [Abstract][Full Text] [Related]
42. Cotransplantation of bone marrow-derived mesenchymal stem cells in haploidentical hematopoietic stem cell transplantation in patients with severe aplastic anemia: an interim summary for a multicenter phase II trial results.
Liu Z; Zhang Y; Xiao H; Yao Z; Zhang H; Liu Q; Wu B; Nie D; Li Y; Pang Y; Fan Z; Li L; Jiang Z; Duan F; Li H; Zhang P; Gao Y; Ouyang L; Yue C; Xie M; Shi C; Xiao Y; Wang S
Bone Marrow Transplant; 2017 May; 52(5):704-710. PubMed ID: 28067873
[TBL] [Abstract][Full Text] [Related]
43. Reduced toxicity, myeloablative HLA-haploidentical hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for sickle cell disease.
Wiebking V; Hütker S; Schmid I; Immler S; Feuchtinger T; Albert MH
Ann Hematol; 2017 Aug; 96(8):1373-1377. PubMed ID: 28573314
[TBL] [Abstract][Full Text] [Related]
44. TcRαβ-depleted haploidentical transplantation results in adult acute leukemia patients.
Kaynar L; Demir K; Turak EE; Öztürk ÇP; Zararsız G; Gönen ZB; Gökahmetoğlu S; Şıvgın S; Eser B; Köker Y; Solmaz M; Ünal A; Çetin M
Hematology; 2017 Apr; 22(3):136-144. PubMed ID: 27724812
[TBL] [Abstract][Full Text] [Related]
45. [Fludarabine-based increased-intensity conditioning regimen for allogeneic hematopoietic stem cell transplantation in acquired severe aplastic anemia].
Sun C; Lin X; Huang Y; Song C; Tao Y; Tu S; Fang J; Chen T; Sun C; Wu B
Zhonghua Xue Ye Xue Za Zhi; 2014 Mar; 35(3):221-4. PubMed ID: 24666488
[TBL] [Abstract][Full Text] [Related]
46. Donor-derived marrow mesenchymal stromal cell co-transplantation following a haploidentical hematopoietic stem cell transplantation trail to treat severe aplastic anemia in children.
Wang Z-; Yu H-; Cao F-; Liu Z-; Liu Z-; Feng W-; Liu X-; Yu Y-; Xiao Y; Li L-; Zhou J
Ann Hematol; 2019 Feb; 98(2):473-479. PubMed ID: 30341538
[TBL] [Abstract][Full Text] [Related]
47. Unrelated donor bone marrow transplantation for children with severe aplastic anemia: minimal GVHD and durable engraftment with partial T cell depletion.
Bunin N; Aplenc R; Iannone R; Leahey A; Grupp S; Monos D; Pierson G
Bone Marrow Transplant; 2005 Feb; 35(4):369-73. PubMed ID: 15640818
[TBL] [Abstract][Full Text] [Related]
48. Immune recovery after in vivo T-cell depletion myeloablative conditioning hematopoietic stem cell transplantation in severe beta-thalassemia children.
Qin F; Shi L; Li Q; Zhang Z; Liu L; Li J; Yang G; Lai YR
Eur J Haematol; 2019 Oct; 103(4):342-350. PubMed ID: 31276236
[TBL] [Abstract][Full Text] [Related]
49. Alternative donor hematopoietic stem cell transplantation for sickle cell disease in Europe.
Gluckman E; Cappelli B; Scigliuolo GM; De la Fuente J; Corbacioglu S
Hematol Oncol Stem Cell Ther; 2020 Dec; 13(4):181-188. PubMed ID: 32201153
[TBL] [Abstract][Full Text] [Related]
50. The role of early natural killer cell adoptive infusion before engraftment in protecting against human herpesvirus-6B encephalitis after naïve T-cell-depleted allogeneic stem cell transplantation.
Gasior M; Ferreras C; de Paz R; Bueno D; Mozo Y; Sisinni L; Canizales JT; González B; Olivas-Mazón R; Marcos A; Romero AB; Constanzo A; Mirones I; Fernández-Arroyo A; Balas A; Vicario JL; Escudero A; Yuste VJ; Pérez-Martínez A
Transfusion; 2021 May; 61(5):1505-1517. PubMed ID: 33713461
[TBL] [Abstract][Full Text] [Related]
51. Comparison of Outcomes of Frontline Immunosuppressive Therapy and Frontline Haploidentical Hematopoietic Stem Cell Transplantation for Children with Severe Aplastic Anemia Who Lack an HLA-Matched Sibling Donor.
Yang S; Yuan X; Ma R; Jiang L; Guo J; Zang Y; Shi J; Yang J; Lei P; Liu Z; Zhang Y; Zhu Z
Biol Blood Marrow Transplant; 2019 May; 25(5):975-980. PubMed ID: 30658223
[TBL] [Abstract][Full Text] [Related]
52. Outcome of unrelated donor stem cell transplantation for children with severe aplastic anemia.
Perez-Albuerne ED; Eapen M; Klein J; Gross TJ; Lipton JM; Baker KS; Woolfrey A; Kamani N
Br J Haematol; 2008 Apr; 141(2):216-23. PubMed ID: 18307564
[TBL] [Abstract][Full Text] [Related]
53. Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLA-haploidentical sibling.
van Rood JJ; Loberiza FR; Zhang MJ; Oudshoorn M; Claas F; Cairo MS; Champlin RE; Gale RP; Ringdén O; Hows JM; Horowitz MH
Blood; 2002 Mar; 99(5):1572-7. PubMed ID: 11861270
[TBL] [Abstract][Full Text] [Related]
54. Haploidentical Hematopoietic Stem Cell Transplantation for Patients with Severe Aplastic Anemia-Single-Centre Experience.
Stavi V; Khaire N; Lipton JH; Kumar R
Curr Oncol; 2024 Feb; 31(3):1246-1252. PubMed ID: 38534926
[TBL] [Abstract][Full Text] [Related]
55. Allogeneic hemopoietic stem cell transplantation (HSCT) for Wiskott-Aldrich syndrome: a report of the Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON).
Muñoz A; Olivé T; Martinez A; Bureo E; Maldonado MS; Diaz de Heredia C; Sastre A; Gonzalez-Vicent M;
Pediatr Hematol Oncol; 2007 Sep; 24(6):393-402. PubMed ID: 17710656
[TBL] [Abstract][Full Text] [Related]
56. Successful Outcome in Patients with Fanconi Anemia Undergoing T Cell-Replete Mismatched Related Donor Hematopoietic Cell Transplantation Using Reduced-Dose Cyclophosphamide Post-Transplantation.
Ayas M; Siddiqui K; Al-Jefri A; Al-Ahmari A; Ghemlas I; Al-Saedi H; Alanazi A; Jafri R; Ayas MF; Al-Seraihi A
Biol Blood Marrow Transplant; 2019 Nov; 25(11):2217-2221. PubMed ID: 31306778
[TBL] [Abstract][Full Text] [Related]
57. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype.
Aversa F; Tabilio A; Velardi A; Cunningham I; Terenzi A; Falzetti F; Ruggeri L; Barbabietola G; Aristei C; Latini P; Reisner Y; Martelli MF
N Engl J Med; 1998 Oct; 339(17):1186-93. PubMed ID: 9780338
[TBL] [Abstract][Full Text] [Related]
58. Alternative donor HSCT in refractory acquired aplastic anemia - prevention of graft rejection and graft versus host disease by immunoablative conditioning and graft manipulation.
Urban C; Benesch M; Sovinz P; Sipurzynski S; Lackner H; Müller E; Schwinger W
Pediatr Transplant; 2012 Sep; 16(6):577-81. PubMed ID: 22462513
[TBL] [Abstract][Full Text] [Related]
59. A Two-Step Haploidentical Versus a Two-Step Matched Related Allogeneic Myeloablative Peripheral Blood Stem Cell Transplantation.
Gaballa S; Palmisiano N; Alpdogan O; Carabasi M; Filicko-O'Hara J; Kasner M; Kraft WK; Leiby B; Martinez-Outschoorn U; O'Hara W; Pro B; Rudolph S; Sharma M; Wagner JL; Weiss M; Flomenberg N; Grosso D
Biol Blood Marrow Transplant; 2016 Jan; 22(1):141-8. PubMed ID: 26415558
[TBL] [Abstract][Full Text] [Related]
60. The Reconstitution of T-cells after Allogeneic Hematopoietic Stem Cell Transplant in a Pediatric Patient with Congenital Amegakaryocytic Thrombocytopenia (CAMT).
Bayegi SN; Hamidieh AA; Behfar M; Saghazadeh A; Bozorgmehr M; Tajik N; Delbandi AA; Delavari S; Shekarabi M; Rezaei N
Endocr Metab Immune Disord Drug Targets; 2024; 24(2):265-272. PubMed ID: 37526450
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]